reference/12608468

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12608468

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	861
issn	1351-0088 1479-6821
issueIdentifier	3
pageRange	851-861
publicationName	Endocrine-Related Cancer
startingPage	851
bibliographicCitation	Sarwar N, Kim JS, Jiang J, Peston D, Sinnett HD, Madden P, Gee JM, Nicholson RI, Lykkesfeldt AE, Shousha S, Coombes RC, Ali S. Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression. Endocr Relat Cancer. 2006 Sep;13(3):851–61. doi: 10.1677/erc.1.01123. PMID: 16954434.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cd13bc7e2c18b6d755cf28421b2a904 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d36d4cd83aec2c5e0c561b200f9a23bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8df2f8e582e76feab36fe5d1aa32c224 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a80a056f9f789025255fe6192eff8131 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d48420f010d126e738277acff9ec02c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1db8fa28635f7f6e5d6f6c92fb54bfa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68a8330a4605a27d912588d37a15a674 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3eb17ef50c71a84702859a2e9486a186 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd0a1de25961de52d6bf6a1379a0784a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1dd5bd9a1b1eb08ab7d8d5c5c4a47c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96a22ed4f539e8e1bd481835fd5d8e37 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b90c0040b1d935da90dafbbbe0f58584
date	200609
identifier	https://doi.org/10.1677/erc.1.01123 https://pubmed.ncbi.nlm.nih.gov/16954434
isPartOf	https://portal.issn.org/resource/ISSN/1479-6821 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21439 https://portal.issn.org/resource/ISSN/1351-0088
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression
discusses	http://id.nlm.nih.gov/mesh/M0021024 http://id.nlm.nih.gov/mesh/M0016735 http://id.nlm.nih.gov/mesh/M0022149 http://id.nlm.nih.gov/mesh/M0280632
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001943Q000378 http://id.nlm.nih.gov/mesh/D047628Q000378 http://id.nlm.nih.gov/mesh/D010768Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D014408 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D013629Q000627 http://id.nlm.nih.gov/mesh/D007150 http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D010766 http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_26e3b3a0ea8ee6116067a3b73abe7e5c http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5951 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d445780815638f183c8f68566998507 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127591104 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128643942 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2099

Total number of triples: 60.